Pages that link to "Q36830998"

The following pages link to Treatment of encephalomyocarditis virus-induced central nervous system demyelination with monoclonal anti-T-cell antibodies (Q36830998):

Displaying 9 items.

• Indirect role of T cells in development of polioencephalitis and encephalomyelitis induced by encephalomyocarditis virus (Q27486228) (← links)
• The encephalomyocarditis virus (Q28715925) (← links)
• Encephalomyocarditis virus 2A protein is required for viral pathogenesis and inhibition of apoptosis (Q28744244) (← links)
• Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies. (Q33784796) (← links)
• Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies (Q35844880) (← links)
• The virology of demyelinating diseases (Q40664855) (← links)
• Biphasic disease of central nervous system induced in DBA/2 mice by the D variant of encephalomyocarditis virus (EMC-D). (Q41161211) (← links)
• Distribution of viral RNA in the spinal cord of DBA/2 mice developing biphasic paralysis following infection with the D variant of encephalomyocarditis virus (EMC-D). (Q41214110) (← links)
• Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies. (Q43517448) (← links)